News | February 25, 2021
Granules India gets USFDA approval of acetaminophen, aspirin and caffeine tablets
ranules now has a total of 38 ANDA approvals from US FDA.
ranules now has a total of 38 ANDA approvals from US FDA.
The company will review FDA's response and decide on appropriate next steps soon.
It is used to treat low blood pressure that causes severe dizziness or a lightheaded feeling.
The inspection concluded with one minor observation in Form 483
GSK holds exclusive global rights (excluding mainland China, Hong Kong, Macau, and Taiwan) from Hansoh Pharma to advance its development and commercialization
The U.S. oncology market is projected to soar from $81 billion in 2025 to $212 billion by 2034
Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the commercialization of FYB206 in the defined territories
Acetaminophen Injection is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older
HYMPAVZI’s safety profile was generally favorable
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Subscribe To Our Newsletter & Stay Updated
